文献速递冠心病

ST段抬高型心肌梗死患者的氧疗:DETO2X-AMI试验预设分析

Oxygen therapy in ST-elevation myocardial infarction.
PubMed 文献 · Eur Heart J · 2018-01-01

DETO2X-AMI试验预设分析纳入2807例接受PCI的STEMI患者,随机分为氧疗组(6 L/min,6-12小时)和空气组,主要复合终点(1年全因死亡、再住院心梗、心源性休克或支架血栓)发生率分别为6.3%和7.5%(HR 0.85, 95%CI 0.64-1.13, P=0.27),无显著差异。结论:对血氧正常的STEMI患者常规吸氧未显著影响1年临床结局。

要点

  • 血氧正常的STEMI患者行直接PCI时,常规吸氧未显著改善1年主要复合终点。
  • 氧疗组与空气组在全因死亡、再住院心梗、心源性休克及支架血栓方面均无显著差异。
  • 预设亚组及不同时间点分析结果一致,提示常规吸氧无获益。

核心结论

  • 对血氧正常的STEMI患者行直接PCI时,常规吸氧未显著影响1年全因死亡、再住院心梗、心源性休克或支架血栓。

研究设计与样本

  • DETO2X-AMI试验预设分析,纳入接受PCI的STEMI患者2807例,随机分为氧疗组(6 L/min,6-12小时,n=1361)和空气组(n=1446)。

主要发现

  • 主要复合终点1年发生率氧疗组6.3%(86/1361) vs 空气组7.5%(108/1446),HR 0.85(95%CI 0.64-1.13),P=0.27。
  • 全因死亡HR 0.86(95%CI 0.61-1.22),P=0.41;再住院心梗HR 0.92(95%CI 0.57-1.48),P=0.73。
  • 再住院心源性休克HR 1.05(95%CI 0.21-5.22),P=0.95;支架血栓HR 1.27(95%CI 0.46-3.51),P=0.64。
  • 主要复合终点在所有亚组及住院期间、30天和随访至1356天期间结果一致。

临床怎么用

  • 对血氧正常的STEMI患者行直接PCI时,常规吸氧无临床获益证据,不应常规使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To determine whether supplemental oxygen in patients with ST-elevation myocardial infarction (STEMI) impacts on procedure-related and clinical outcomes. METHODS AND RESULTS: The DETermination of the role of Oxygen in suspected Acute Myocardial Infarction (DETO2X-AMI) trial randomized patients with suspected myocardial infarction (MI) to receive oxygen at 6 L/min for 6-12 h or ambient air. In this pre-specified analysis, we included only STEMI patients who underwent percutaneous coronary intervention (PCI). In total, 2807 patients were included, 1361 assigned to receive oxygen, and 1446 assigned to ambient air. The pre-specified primary composite endpoint of all-cause death, rehospitalization with MI, cardiogenic shock, or stent thrombosis at 1 year occurred in 6.3% (86 of 1361) of patients allocated to oxygen compared to 7.5% (108 of 1446) allocated to ambient air [hazard ratio (HR) 0.85, 95% confidence interval (95% CI) 0.64-1.13; P = 0.27]. There was no difference in the rate of death from any cause (HR 0.86, 95% CI 0.61-1.22; P = 0.41), rate of rehospitalization for MI (HR 0.92, 95% CI 0.57-1.48; P = 0.73), rehospitalization for cardiogenic shock (HR 1.05, 95% CI 0.21-5.22; P = 0.95), or stent thrombosis (HR 1.27, 95% CI 0.46-3.51; P = 0.64). The primary composite endpoint was consistent across all subgroups, as well as at different time points, such as during hospital stay, at 30 days and the total duration of follow-up up to 1356 days. CONCLUSIONS: Routine use of supplemental oxygen in normoxemic patients with STEMI undergoing primary PCI did not significantly affect 1-year all-cause death, rehospitalization with MI, cardiogenic shock, or stent thrombosis.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Hofmann R, Witt N, Lagerqvist B, et al. Oxygen therapy in ST-elevation myocardial infarction. Eur Heart J. 2018. PMID: 29912429. doi:10.1093/eurheartj/ehy326

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。